Injective consolidates between $3.88 and $4.34 amid muted momentum signals: weekly review

Traders Union
All News
Crypto
Injective rises 10.05% this week

Highlights

INJ shows short-term upward momentum but remains in a broader medium- and long-term downtrend, trading well below key moving average resistance levels.
Momentum indicators and oscillators are mixed, with weak underlying trend signals and overbought readings despite a 10% weekly price gain.
INJ is expected to consolidate between $3.88 and $4.34 over the next week, with downside risk outweighing potential for a breakout above resistance.

Overbought signals and weak momentum cap gains during the week

On the weekly timeframe, INJ’s MA-20 acts as dynamic support, with MA-50 and MA-200 positioned high above and capping upside potential. Weekly indicators show weak momentum: MACD remains strongly bearish, ADX points to a sustained downtrend, and both RSI and CCI suggest muted momentum. Despite recent advances, Stochastic RSI and Bull/Bear Power highlight overbought conditions and persistent buyer pressure, while overall volatility stands elevated at 19.07%.

Sideways range favored as bullish signals remain scarce for next week

Over the next 7 days, INJ is expected to consolidate between $3.88 and $4.34 as volatility remains high. Technical signals reflect a low probability (less than 20%) for further upward movement, as none of the four key indicators provide a bullish outlook. The baseline scenario anticipates sideways trading in this zone. A close above resistance at $4.34 could allow a move toward $4.50, while a drop below support at $3.88 may trigger a decline to $3.70.

Viktoras Karapetjanc, analyst at Traders Union, sees Injective’s recent price recovery as a sign of resilience despite the dominant downtrend pressures. He notes that INJ stayed comfortably above its MA-20 this week, but longer-term moving averages still reflect seller control. Volatility remains elevated and the momentum signals are split, with overbought readings yet limited bullish confirmation. Karapetjanc believes the next week favors consolidation between $3.88 and $4.34, with breakout potential providing extra opportunity. "If resistance at $4.34 is overcome, I expect bulls to step in quickly and target the $4.50 area."

Earlier, analysts noted that Injective showed renewed bullish momentum but faced downside risks due to overbought technical conditions. The latest weekly data strengthens this cautious outlook, with persistent weak momentum and high volatility reinforcing the likelihood of rangebound trading and making a decisive close above $4.34 a key level for confirming any short-term bullish reversal.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.